Electronic Anesthetic Efficacy Prof. Ali Rokia Ph.D. Al-Andalus University Prof . Mouetaz Kheirallah Ph.D ArabUST

NCT ID: NCT07257432

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-24

Study Completion Date

2026-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Spilt Mouth Clinical Comparative Evaluation Of The Electronic Anesthetic Efficacy Comparison of traditional local anesthesia with electronic local anesthesia in terms of the ability to reduce pain during injection and the duration of the anesthetic effect

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design:

The mouth will be split in half using a split mouth study. The lower anterior teeth will be injected with a conventional local anesthetic syringe on one side, and the patient will be injected with an electronic anesthetic syringe on the other side.

The study will be conducted on a sample of volunteers aged 18 to 30 years at the Faculty of Dentistry at Al-Andalus University.

The objectives and procedure will be explained to each group of patients, and informed consent will be obtained from each patient to accept the research procedures.

A 2% non-vasoconstrictor lidocaine local anesthetic will be used for all patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Perception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The split-mouth design was applied to the study group, with one arm for therapeutic intervention involving Smartject injection , and the other arm involving traditional injectors
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Caregivers Investigators
single blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electronic syringe therapeutic intervention arm

During the appointment, the subjects randomly received 1.8 ml of 2% plain lidocaine for the Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side, while Smartject was used on the experimental side

Group Type EXPERIMENTAL

Experimental group: Electronic syringe therapeutic intervention arm

Intervention Type DRUG

Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side, while Smartject was used on the experimental side

control group: therapeutic intervention using a traditional syringe

Intervention Type DRUG

During the appointment, the subjects randomly received 1.8 ml of 2% plain lidocaine for the Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side

therapeutic intervention using a traditional syringe

During the appointment, the subjects randomly received 1.8 ml of 2% plain lidocaine for the Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side, while Smartject was used on the experimental side

Group Type EXPERIMENTAL

Experimental group: Electronic syringe therapeutic intervention arm

Intervention Type DRUG

Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side, while Smartject was used on the experimental side

control group: therapeutic intervention using a traditional syringe

Intervention Type DRUG

During the appointment, the subjects randomly received 1.8 ml of 2% plain lidocaine for the Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental group: Electronic syringe therapeutic intervention arm

Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side, while Smartject was used on the experimental side

Intervention Type DRUG

control group: therapeutic intervention using a traditional syringe

During the appointment, the subjects randomly received 1.8 ml of 2% plain lidocaine for the Intraoral Mental nerve block on both sides (experimental and control). A Carpule syringe with an aspiration and short needles 30G were used on the control side

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

anesthesia pen x surgimax

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

allergic to local anesthetics ,females during menstural cycle ,bad oral care.
Minimum Eligible Age

20 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mouetaz Kheirallah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mouetaz Kheirallah

Ph.D., OMFS, DDS, Associate Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ali G Rokia, ph.D

Role: STUDY_CHAIR

Al-Andalus University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Al Andalus University

Tartous, Al Kadmous, Syria

Site Status

Arab University

Hama, , Syria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Syria

References

Explore related publications, articles, or registry entries linked to this study.

Douglas BL. Electronic dental anesthesia. Anesth Prog. 1993;40(3):99-100. No abstract available.

Reference Type BACKGROUND
PMID: 7645794 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ArabUST

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.